BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 8951485)

  • 21. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
    Feakins RM; Wells CA; Young KA; Sheaff MT
    Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast.
    Sawyer EJ; Hanby AM; Poulsom R; Jeffery R; Gillett CE; Ellis IO; Ellis P; Tomlinson IP
    J Pathol; 2003 Aug; 200(5):627-32. PubMed ID: 12898599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
    Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
    Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
    Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of anaphase-promoting complex7 in fibroadenomas and phyllodes tumors of breast.
    Kang Y; Kim JH; Lee TH; Kim TS; Jung WH; Chung HC; Park BW; Sheen SS; Han JH
    Hum Pathol; 2009 Jan; 40(1):98-107. PubMed ID: 18789487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.
    Jara-Lazaro AR; Akhilesh M; Thike AA; Lui PC; Tse GM; Tan PH
    Histopathology; 2010 Aug; 57(2):220-32. PubMed ID: 20716164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay.
    Kuijper A; Buerger H; Simon R; Schaefer KL; Croonen A; Boecker W; van der Wall E; van Diest PJ
    J Pathol; 2002 Aug; 197(5):575-81. PubMed ID: 12210075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrohistiocytic differentiation in subcutaneous fatty tumors. Study of spindle cell, pleomorphic, myxoid, and atypical lipoma and dedifferentiated liposarcoma cases composed in part of CD34+ fibroblasts and FXIIIa+ histiocytes.
    Silverman JS; Tamsen A
    J Cutan Pathol; 1997 Sep; 24(8):484-93. PubMed ID: 9331894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myxoid dermatofibrohistiocytoma: an indolent post-traumatic tumor composed of CD34+ epithelioid and dendritic cells and factor XIIIa+ dendrophages.
    Silverman JS; Brustein S
    J Cutan Pathol; 1996 Dec; 23(6):551-7. PubMed ID: 9001986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudoangiomatous hyperplasia of mammary stroma: a case of pure type after removal of fibroadenoma.
    Fukunaga M
    APMIS; 2001 Feb; 109(2):113-6. PubMed ID: 11398992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions.
    Chauhan H; Abraham A; Phillips JR; Pringle JH; Walker RA; Jones JL
    J Clin Pathol; 2003 Apr; 56(4):271-6. PubMed ID: 12663638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.
    Feakins RM; Mulcahy HE; Nickols CD; Wells CA
    Histopathology; 1999 Aug; 35(2):162-9. PubMed ID: 10460662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
    Bode MK; Rissanen T; Apaja-Sarkkinen M
    Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleomorphic hyalinizing angiectatic tumor of soft parts: immunohistochemical case study shows cellular composition by CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Dana MM
    J Cutan Pathol; 1997 Jul; 24(6):377-83. PubMed ID: 9243366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonality in fibroadenomas with complex histology and phyllodal features.
    Kasami M; Vnencak-Jones CL; Manning S; Dupont WD; Jensen RA; Page DL
    Breast Cancer Res Treat; 1998 Jul; 50(2):185-91. PubMed ID: 9822223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential cytologic features of fibroepithelial lesions of the breast.
    Deen SA; McKee GT; Kissin MW
    Diagn Cytopathol; 1999 Feb; 20(2):53-6. PubMed ID: 9951596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructure of cystosarcoma phyllodes and fibroadenoma. A comparative study.
    Yeh IT; Francis DJ; Orenstein JM; Silverberg SG
    Am J Clin Pathol; 1985 Aug; 84(2):131-6. PubMed ID: 2992265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent MED12 mutations in phyllodes tumours of the breast.
    Yoshida M; Sekine S; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Ochiai A
    Br J Cancer; 2015 May; 112(10):1703-8. PubMed ID: 25839987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.
    Umekita Y; Yoshida H
    Pathol Int; 1999 Sep; 49(9):807-10. PubMed ID: 10504552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.